| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |